Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Invicta Diagnostic Ltd

NSE: INVICTA · Healthcare · 36 announcements

Share price
₹66.50
Market cap
₹83.60 Cr
Revenue (annual)
₹32.35 Cr
Net profit (annual)
₹4.91 Cr
P/E (TTM)
17.0×Sector 53.1×
Promoter holding
66.70%
FII holding
4.20%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:56 IST NSE
Merger & Restructuring

Invicta Diagnostic Merger & Restructuring Worth ₹0.01 Cr

Invicta Diagnostic Limited is selling its associate entity, MSCRIBEIT INFOTECH LLP, for a cash consideration of Rs. 50,000. The transaction is expected to conclude by March 2027.

Value
₹0.01 Cr
20:13 IST NSE
Merger & Restructuring

Invicta Diagnostic Merger & Restructuring

Invicta Diagnostic Limited completed the incorporation of a new diagnostics LLP. The execution of the initial partnership agreement marks the entity's formal establishment.

21:14 IST NSE
Merger & Restructuring

Invicta Diagnostic Merger & Restructuring Worth ₹0.01 Cr

Invicta Diagnostic Limited incorporated a new step-down subsidiary, Porteus Pathogenius LLP, with ₹0.01 Crore capital. The entity will expand the group's diagnostics and pathology service footprint.

Value
₹0.01 Cr
Execution
One Month
21:03 IST NSE
Merger & Restructuring

Invicta Diagnostic Merger & Restructuring

Invicta Diagnostic Limited completed the sale of its 47% stake in Porteus Medical LLP. This transaction finalizes the divestment for a consideration of ₹47,000.